Patricia Palmeira

Patricia Palmeira

Auto-generated profile, based on publicly available information

Patricia Palmeira

Laboratorio de Pediatria Clinica (LIM-36), Departamento de Pediatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Clinics
Verified
Journal Article
Open access
TFThais T. Fink
Thais T. Fink
HMHeloisa H.S. Marques
Heloisa H.S. Marques
BGBruno Gualano
Bruno Gualano
LLLivia Lindoso
Livia Lindoso
VBVera Bain
Vera Bain
YZYingying Zheng
Yingying Zheng
To prospectively evaluate demographic, anthropometric and health-related quality of life (HRQoL) in pediatric patients with laboratory-confirmed coronavirus disease 2019 (COVID-19) This was a longitudinal observational study of surviving pediatric post-COVID-19 patients (n=53) and pediatric subjects without laboratory-confirmed COVID-19 included as controls (n=52) was performed. The median duration between COVID-19 diagnosis (n=53) and follow-up was 4.4 months (0.8-10.7). Twenty-three of 53 (43%) patients reported at least one persistent symptom at the longitudinal follow-up visit and 12/53 (23%) had long COVID-19, with at least one symptom lasting for >12 weeks. The most frequently reported symptoms at the longitudinal follow-up visit were headache (19%), severe recurrent headache (9%), tiredness (9%), dyspnea (8%), and concentration difficulty (4%). At the longitudinal follow-up visit, the frequencies of anemia (11% versus 0%, p=0.030), lymphopenia (42% versus 18%, p=0.020), C-reactive protein level of >30 mg/L (35% versus 0%, p=0.0001), and D-dimer level of >1000 ng/mL (43% versus 6%, p=0.0004) significantly reduced compared with baseline values. Chest X-ray abnormalities (11% versus 2%, p=0.178) and cardiac alterations on echocardiogram (33% versus 22%, p=0.462) were similar at both visits. Comparison of characteristic data between patients with COVID-19 at the longitudinal follow-up visit and controls showed similar age (p=0.962), proportion of male sex (p=0.907), ethnicity (p=0.566), family minimum monthly wage (p=0.664), body mass index (p=0.601), and pediatric pre-existing chronic conditions (p=1.000). The Pediatric Quality of Live Inventory 4.0 scores, median physical score (69 [0-100] versus 81 [34-100], p=0.012), and school score (60 [15-100] versus 70 [15-95], p=0.028) were significantly lower in pediatric patients with COVID-19 at the longitudinal follow-up visit than in controls. Pediatric patients with COVID-19 showed a longitudinal impact on HRQoL parameters, particularly in physical/school domains, reinforcing the need for a prospective multidisciplinary approach for these patients. These data highlight the importance of closer monitoring of children and adolescents by the clinical team after COVID-19.

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
PPPatricia Palmeira
Patricia Palmeira
JBJosé Alexandre Marzagao Barbuto
José Alexandre Marzagao Barbuto
CSClovis Artur A Silva
Clovis Artur A Silva
MCMagda Carneiro-Sampaio
Magda Carneiro-Sampaio
Acute respiratory viral diseases, like most other infectious diseases, affect mainly infants and young children, who present with 6-8 episodes per year and usually develop more severe manifestations than in adults. It is well-documented that innate antiviral immune responses in early life are characterized by lower type I interferon (IFN) responses () and reduced natural killer cell activity, which despite their higher numbers exhibit lower cytotoxic capacity and reduced number of cytoplasmic granules and degranulation ability (). Additionally, lower cytotoxic [...] Acute respiratory viral diseases, like most other infectious diseases, affect mainly infants and young children, who present with 6-8 episodes per year and usually develop more severe manifestations than in adults. It is well-documented that innate antiviral immune responses in early life are characterized by lower type I interferon (IFN) responses () and reduced natural killer cell activity, which despite their higher numbers exhibit lower cytotoxic capacity and reduced number of cytoplasmic granules and degranulation ability (). Additionally, lower cytotoxic

1 January 2021 in Clinics
Verified
Journal Article
Open access
VCValdenise Martins Laurindo Tuma Calil
Valdenise Martins Laurindo Tuma Calil
PPPatricia Palmeira
Patricia Palmeira
YZYingying Zheng
Yingying Zheng
VKVera Lúcia Jornada Krebs
Vera Lúcia Jornada Krebs
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
MCMagda Carneiro-Sampaio
Magda Carneiro-Sampaio

10 August 2022 in Clinics
Verified
Journal Article
Open access
YZYingying Zheng
Yingying Zheng
SCSimone Correa-Silva
Simone Correa-Silva
PPPatricia Palmeira
Patricia Palmeira
MCMagda Carneiro-Sampaio
Magda Carneiro-Sampaio
• Human milk is an essential source of immunonutrients for the nursing infant. • Maternal vaccination provides specific IgA and IgG antibodies in breast milk. • Milk from vaccinated mothers contains anti-SARS-CoV-2 antibodies that may protect the infant.

1 May 2020 in Cytokine
Verified
Journal Article
Closed access
YZYingying Zheng
Yingying Zheng
SCSimone Corrêa-Silva
Simone Corrêa-Silva
ESEloisa Corrêa de Souza
Eloisa Corrêa de Souza
RRRegina Maria Rodrigues
Regina Maria Rodrigues
FFFernanda A. Macaferri da Fonseca
Fernanda A. Macaferri da Fonseca
PPPatricia Palmeira
Patricia Palmeira

17 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SBSilvia Yumi Bando
Silvia Yumi Bando
FBFernanda Bernardi Bertonha
Fernanda Bernardi Bertonha
SFSandra Elisabete FMUSP
Sandra Elisabete FMUSP
DODanielle Oliveira
Danielle Oliveira
VCVanessa N. Chalup
Vanessa N. Chalup
CMCarlos Alberto Moreira-Filho
Carlos Alberto Moreira-Filho
Since the molecular mechanisms determining COVID-19 severity are not yet well understood, there is a demand for biomarkers derived from comparative transcriptome analyses of mild and severe cases, combined with patients’ clinico-demographic and laboratory data. Here the transcriptomic response of human leukocytes to SARS-CoV-2 infection was investigated by focusing on the differences between mild and severe cases and between age subgroups (younger and older adults). Three transcriptional modules correlated with these traits were functionally characterized, as well as 23 differentially expressed genes (DEGs) associated to disease severity. One module, correlated with severe cases and older patients, had an overrepresentation of genes involved in innate immune response and in neutrophil activation, whereas two other modules, correlated with disease severity and younger patients, harbored genes involved in the innate immune response to viral infections, and in the regulation of this response. This transcriptomic mechanism could be related to the better outcome observed in younger COVID-19 patients. The DEGs, all hyper-expressed in the group of severe cases, were mostly involved in neutrophil activation and in the p53 pathway, therefore related to inflammation and lymphopenia. These biomarkers may be useful for getting a better stratification of risk factors in COVID-19.